Home/Filings/4/0001103021-22-000074
4//SEC Filing

Vollins James 4

Accession 0001103021-22-000074

CIK 0001103021other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 5:18 PM ET

Size

16.9 KB

Accession

0001103021-22-000074

Insider Transaction Report

Form 4
Period: 2022-03-22
Vollins James
See Remarks
Transactions
  • Disposition to Issuer

    Stock Options (right to buy)

    2022-03-2229,8260 total
    Exercise: $3.46Common Stock (29,826 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2022-03-22269,2440 total
    Exercise: $3.84Common Stock (269,244 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2022-03-22282,0550 total
    Exercise: $3.66Common Stock (282,055 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2022-03-2243,3340 total
    Exercise: $3.90Common Stock (43,334 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2022-03-2282,5080 total
    Exercise: $3.03Common Stock (82,508 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2022-03-2291,4010 total
    Exercise: $0.00Common Stock (91,401 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one Share.
  • [F2]Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration.
  • [F3]Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an "In-the-Money Cash Out Option") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration.

Issuer

BIODELIVERY SCIENCES INTERNATIONAL INC

CIK 0001103021

Entity typeother

Related Parties

1
  • filerCIK 0001757833

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:18 PM ET
Size
16.9 KB